Dachaigh › Ailseachadh an Ae (Carcinoma Hepatocellular) › Washington › Seattle
Sgrùdaidhean clionaigeach Ailseachadh an Ae (Carcinoma Hepatocellular) ann an Seattle, WA
Tha 10 sgrùdaidhean airson Ailseachadh an Ae (Carcinoma Hepatocellular) a’ lorg phàirtichean aig làraichean ann agus timcheall air Seattle (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
A’ fastadhÌre 1/2
- Research Facility, Seattle
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
A’ fastadhÌre 1/2
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center- Montlake, Seattle
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
A’ fastadhÌre 1/2
- Local Institution - 0083, Seattle
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
A’ fastadhÌre 1/2
- Fred Hutchinson Cancer Center, University of Washington, Seattle
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
A’ fastadhÌre 3
- Research Site, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A’ fastadhÌre 2
- University of Washington School of Medicine, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
A’ fastadh
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
A’ fastadhÌre 1/2
- Virginia Mason Medical Center, Seattle
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
A’ fastadhÌre 1
- Seattle Children's Hospital, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Seattle
Sgrùdaidhean Ailseachadh an Ae (Carcinoma Hepatocellular) ann am bailtean eile
- Houston, TX31 sgrùdaidhean
- New York City, NY24 sgrùdaidhean
- Dallas, TX19 sgrùdaidhean
- Los Angeles, CA19 sgrùdaidhean
- Boston, MA18 sgrùdaidhean
- Cleveland, OH18 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- Pittsburgh, PA15 sgrùdaidhean
- San Francisco, CA14 sgrùdaidhean
- Orange, CA14 sgrùdaidhean
- Jacksonville, FL14 sgrùdaidhean
Sgrùdaidhean eile ann an Seattle
- Aillse Sgamhain Neo-chealla-beag53 sgrùdaidhean
- Aillse (gach seòrsa)49 sgrùdaidhean
- Aillse Prostata42 sgrùdaidhean
- Leukemia myeloid geur41 sgrùdaidhean
- Aillse a' bhroilleach39 sgrùdaidhean
- Ailse metastatach39 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Ailseachadh nan Sgamhan33 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Myeloma iomaill22 sgrùdaidhean
- Aillse sa bhlaire21 sgrùdaidhean
- Siondròman Myelodysplastic21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.